StockData
Alumis Inc. logo

Alumis Inc. (ALMS) stock

ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$4.39−0.45 (-9.19%)

Close on Nov 18, 2026Market cap $568.87MP/E –Yield –

Alumis operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Alumis's operating income for the twelve months ending Jun 30, 2026 was -$459.00M. For fiscal 2025 it was -$453.80M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$453.80M–
FY2024Dec 31, 2024-$300.75M–
FY2023Dec 31, 2023-$158.17M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$148.86M–
Q1 FY2026Mar 31, 2026-$98.41M–
Q4 FY2025Dec 31, 2025-$96.45M–
Q3 FY2025Sep 30, 2025-$115.29M–
Q2 FY2025Jun 30, 2025-$140.54M–
Q1 FY2025Mar 31, 2025-$101.53M–
Q4 FY2024Dec 31, 2024-$98.62M–
Q3 FY2024Sep 30, 2024-$98.40M–
Q2 FY2024Jun 30, 2024-$56.14M–
Q1 FY2024Mar 31, 2024-$47.59M–
Q4 FY2023Dec 31, 2023-$40.13M–
Q3 FY2023Sep 30, 2023-$43.76M–
Q2 FY2023Jun 30, 2023-$37.62M–

More Alumis figures

See a number that looks wrong?